These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 34058326)
1. Natural products as drugs and tools for influencing core processes of eukaryotic mRNA translation. Burgers LD; Fürst R Pharmacol Res; 2021 Aug; 170():105535. PubMed ID: 34058326 [TBL] [Abstract][Full Text] [Related]
2. Natural products targeting the elongation phase of eukaryotic protein biosynthesis. Brönstrup M; Sasse F Nat Prod Rep; 2020 Jun; 37(6):752-762. PubMed ID: 32428051 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of Eukaryotic Translation by the Antitumor Natural Product Agelastatin A. McClary B; Zinshteyn B; Meyer M; Jouanneau M; Pellegrino S; Yusupova G; Schuller A; Reyes JCP; Lu J; Guo Z; Ayinde S; Luo C; Dang Y; Romo D; Yusupov M; Green R; Liu JO Cell Chem Biol; 2017 May; 24(5):605-613.e5. PubMed ID: 28457705 [TBL] [Abstract][Full Text] [Related]
4. Exploring natural products-based cancer therapeutics derived from egyptian flora. El-Seedi HR; Yosri N; Khalifa SAM; Guo Z; Musharraf SG; Xiao J; Saeed A; Du M; Khatib A; Abdel-Daim MM; Efferth T; Göransson U; Verpoorte R J Ethnopharmacol; 2021 Apr; 269():113626. PubMed ID: 33248183 [TBL] [Abstract][Full Text] [Related]
5. Investigations on the mode of action of gephyronic acid, an inhibitor of eukaryotic protein translation from myxobacteria. Muthukumar Y; Münkemer J; Mathieu D; Richter C; Schwalbe H; Steinmetz H; Kessler W; Reichelt J; Beutling U; Frank R; Büssow K; van den Heuvel J; Brönstrup M; Taylor RE; Laschat S; Sasse F PLoS One; 2018; 13(7):e0201605. PubMed ID: 30063768 [TBL] [Abstract][Full Text] [Related]
6. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease. Sahoo AK; Dandapat J; Dash UC; Kanhar S J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451 [TBL] [Abstract][Full Text] [Related]
7. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. Wang L; Waltenberger B; Pferschy-Wenzig EM; Blunder M; Liu X; Malainer C; Blazevic T; Schwaiger S; Rollinger JM; Heiss EH; Schuster D; Kopp B; Bauer R; Stuppner H; Dirsch VM; Atanasov AG Biochem Pharmacol; 2014 Nov; 92(1):73-89. PubMed ID: 25083916 [TBL] [Abstract][Full Text] [Related]
8. Natural medicines for the treatment of fatigue: Bioactive components, pharmacology, and mechanisms. Luo C; Xu X; Wei X; Feng W; Huang H; Liu H; Xu R; Lin J; Han L; Zhang D Pharmacol Res; 2019 Oct; 148():104409. PubMed ID: 31446039 [TBL] [Abstract][Full Text] [Related]
9. The pharmacogenetics of natural products: A pharmacokinetic and pharmacodynamic perspective. Rao T; Tan Z; Peng J; Guo Y; Chen Y; Zhou H; Ouyang D Pharmacol Res; 2019 Aug; 146():104283. PubMed ID: 31129178 [TBL] [Abstract][Full Text] [Related]
10. Ethnobotany, phytochemistry and pharmacology of Arctotis arctotoides (L.f.) O. Hoffm.: A review. Saleh-E-In MM; Van Staden J J Ethnopharmacol; 2018 Jun; 220():294-320. PubMed ID: 29331315 [TBL] [Abstract][Full Text] [Related]
11. The Translation Inhibitor Rocaglamide Targets a Bimolecular Cavity between eIF4A and Polypurine RNA. Iwasaki S; Iwasaki W; Takahashi M; Sakamoto A; Watanabe C; Shichino Y; Floor SN; Fujiwara K; Mito M; Dodo K; Sodeoka M; Imataka H; Honma T; Fukuzawa K; Ito T; Ingolia NT Mol Cell; 2019 Feb; 73(4):738-748.e9. PubMed ID: 30595437 [TBL] [Abstract][Full Text] [Related]
12. The cave microbiome as a source for drug discovery: Reality or pipe dream? Ghosh S; Kuisiene N; Cheeptham N Biochem Pharmacol; 2017 Jun; 134():18-34. PubMed ID: 27867014 [TBL] [Abstract][Full Text] [Related]
13. Versatile Synthetic Route to Cycloheximide and Analogues That Potently Inhibit Translation Elongation. Park Y; Koga Y; Su C; Waterbury AL; Johnny CL; Liau BB Angew Chem Int Ed Engl; 2019 Apr; 58(16):5387-5391. PubMed ID: 30802354 [TBL] [Abstract][Full Text] [Related]
14. Chlorolissoclimides: new inhibitors of eukaryotic protein synthesis. Robert F; Gao HQ; Donia M; Merrick WC; Hamann MT; Pelletier J RNA; 2006 May; 12(5):717-25. PubMed ID: 16540697 [TBL] [Abstract][Full Text] [Related]
15. Plumeria rubra L.- A review on its ethnopharmacological, morphological, phytochemical, pharmacological and toxicological studies. Bihani T J Ethnopharmacol; 2021 Jan; 264():113291. PubMed ID: 32841700 [TBL] [Abstract][Full Text] [Related]
16. Dissecting the Nucleoside Antibiotics as Universal Translation Inhibitors. Nelli MR; Heitmeier KN; Looper RE Acc Chem Res; 2021 Jul; 54(13):2798-2811. PubMed ID: 34152729 [TBL] [Abstract][Full Text] [Related]
17. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/β-catenin-VEGF signaling pathway in Lewis lung cancer. Han D; Cao C; Su Y; Wang J; Sun J; Chen H; Xu A J Ethnopharmacol; 2016 Nov; 192():406-412. PubMed ID: 27649680 [TBL] [Abstract][Full Text] [Related]
18. Natural isoquinoline alkaloids: Pharmacological features and multi-target potential for complex diseases. Plazas E; Avila M MC; Muñoz DR; Cuca S LE Pharmacol Res; 2022 Mar; 177():106126. PubMed ID: 35151857 [TBL] [Abstract][Full Text] [Related]
19. Cell death regulation: A new way for natural products to treat osteoporosis. Li Z; Li D; Chen R; Gao S; Xu Z; Li N Pharmacol Res; 2023 Jan; 187():106635. PubMed ID: 36581167 [TBL] [Abstract][Full Text] [Related]
20. Potentially active compounds that improve PAD through angiogenesis: A review. Liu ZB; Fan XY; Wang CW; Ye X; Wu CJ Biomed Pharmacother; 2023 Dec; 168():115634. PubMed ID: 37879211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]